US EditionPublished • loading... • Updated
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit
Lawsuit claims Inspire Medical Systems misled investors on Inspire V readiness and demand, causing an 80% earnings guidance cut and a 32% stock drop, firm says.
- Nov. 08, 2025, Inspire Medical Systems, Inc. faces a proposed class action alleging it misled investors about Inspire V commercial readiness and demand in the case styled City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems.
- Inspire had assured investors it met regulatory, technical, and commercial prerequisites, but billing software updates delayed until July 1, incomplete training, and `burn down` of Inspire IV inventory limited Inspire V uptake.
- Following the disclosure, shares dropped $42.04 and roughly 32%, with Inspire cutting 2025 earnings guidance by 80% to $0.40 to $0.50 per share.
- Hagens Berman urges affected investors to submit losses and notes a Jan. 5, 2026 lead-plaintiff deadline; whistleblowers may seek up to 30 percent rewards under the SEC Whistleblower program.
- Hagens Berman, a plaintiffs' rights firm that has secured more than $2.9 billion, said it will probe whether Inspire intentionally misled investors amid the disastrous Inspire V rollout.
Insights by Ground AI
37 Articles
37 Articles
Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman - Inspire Medical Systems (NYSE:INSP)
SAN FRANCISCO, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and
·New York, United States
Read Full ArticleCoverage Details
Total News Sources37
Leaning Left6Leaning Right2Center14Last UpdatedBias Distribution64% Center
Bias Distribution
- 64% of the sources are Center
64% Center
L 27%
C 64%
Factuality
To view factuality data please Upgrade to Premium
